BK polyomavirus (BKPyV) infection of the kidney graft remains a major clinical issue in the
field of organ transplantation. Risk factors for BKPyV-associated nephropathy (BKPyVAN) …

Urine CXCL10 is a well characterized inflammation biomarker, which can be used to guide
performance of surveillance biopsies. Wide implementation into clinical practice depends on …

ABSTRACT BK polyomavirus (BKPyV) contributes to premature renal failure in 10%–20% of
kidney transplant recipients. Current treatment relies on reducing immunosuppression to …

The human polyomavirus, JCPyV, establishes a lifelong persistent infection in the peripheral
organs of a majority of the human population worldwide. Patients who are …

Background In kidney transplant recipients (KTR), BK polyomavirus-associated nephropathy
(BKPyVAN) is a major cause of graft loss. To facilitate the clearance of BKPyV-DNAemia …

Abstract Background Urinary CXCL10/creatinine (uCXCL10/Cr) is proposed as an effective
biomarker of subclinical rejection in pediatric kidney transplant recipients. This study …

BK polyomavirus (BKPyV) is a ubiquitous human polyomavirus and a major infection after
kidney transplantation, primarily due to immunosuppression. BKPyV reactivation can …

See related letter to the editor,“Of Endpoints and Context of Use: A Reasonable Silver Lining
for Urinary Chemokines Monitoring,” on pages 1765–1766 and original article,“Randomized …

Although BK polyomavirus (BKPyV) was first isolated from the urine of a kidney transplant
recipient> 50 y ago, to date, no prophylactic strategy or effective antiviral therapy exists. The …

Completely unknown before the 90s and exceptional up to the 2000s, BK virus nephropathy
(BKvN), usually known as polyomavirus-associated nephropathy, has emerged as a …